For every treatment team and researcher to have instant access to expert opinions and the latest evidence-based information in multiple myeloma, to aid in treatment decisions and improve the lives of patients with multiple myeloma globally.
Enhance the collective knowledge base in multiple myeloma through global multichannel dissemination of the most up-to-date evidence-based information in multiple myeloma, to help inform on disease management and treatment strategies.
The MM Hub was founded in partnership with the European School of Haematology (ESH) in 2017. The ESH is a not-for-profit institution for the dissemination of information and lifelong learning founded in 1985 to promote and facilitate access to state-of-the-art and cutting-edge knowledge in hematology and related disciplines at the European level. ESH conferences showcase state-of-the-art science and provide insights into new developments in the fields of basic, clinical, and therapeutic research in hematology.
The MM Hub is brought to you by Scientific Education Support (SES). SES loves nothing more than building communities and networks to facilitate education through collaboration, ensuring that patients have access to the latest support and treatment options. The SES team takes care of the everyday management, content generation, and uploads onto the MM Hub, assisting the Steering Committee in keeping the site as up-to-date as possible.